AptaGraph

Target · 3 names match

HepG2

33 aptamers in 33 source records from 5 papers; 33 carry a Kd.

Also matches 1 identity

HepG2Hepatoma Hep…Human-derived…Papers by yearKd 1 pM1 nM1 µMNo Kd2013 Bioorganic & Medici…2013 Bioorganic & Medici…2015 PLoS ONE2016 PLoS ONEdoi:10.1093/abbs/gmt130Proteins enriched hereKd 1 pM1 nM1 µMNo KdprothrombinProthrombinAlbuminalpha-fetoproteinserotransferrinalbuminretinol-binding protein 4Complement C5Glutathione S-transferas…1Names as recorded3 ways of writing this target in thesource databases, resolved to 1identity (cellosaurus:CVCL_0027).2Every binding traced33 records from 5 papers.3Tightest binderC-2, Kd 19 nM; 50 nt DNA. Closer tothe centre is tighter.4Sequence families24 links between aptamers where onesequence contains the other.DNA aptamerRNA aptamerModifiedTarget identityPaperCellOne sequence contains the other
SVG CSV

The records behind the plot

33 source records. All of them as CSV.

AptamerKindLength (nt)Target, as writtenKdMethodYearPaperSource record
C-2 DNA50 HepG2 19 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
C-2 DNA95 Hepatoma HepG2 cells, Human 19 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
C-1 DNA50 HepG2 20 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
C-1 DNA95 Hepatoma HepG2 cells, Human 20 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
B-2 DNA50 HepG2 27 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
B-2 DNA95 Hepatoma HepG2 cells, Human 27 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
C-3 DNA50 HepG2 50 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
C-3 DNA95 Hepatoma HepG2 cells, Human 50 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
E-1 DNA50 HepG2 64 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
JHIT2 DNA25 HepG2 64 nM 2015 PLoS ONE AptaNexus
E-1 DNA95 Hepatoma HepG2 cells, Human 64 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
HA09 DNA80 Human-derived hepatoma cell line HepG2 104 nM source Kd doi:10.1093/abbs/gmt130 UTexas
B-1 DNA50 HepG2 111 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
B-1 DNA95 Hepatoma HepG2 cells, Human 111 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
C-4 DNA50 HepG2 141 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
C-4 DNA95 Hepatoma HepG2 cells, Human 141 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
G-1 DNA50 HepG2 153 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
G-1 DNA95 Hepatoma HepG2 cells, Human 153 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
D-1 DNA50 HepG2 195 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
D-1 DNA95 Hepatoma HepG2 cells, Human 195 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
JHIT1 DNA25 HepG2 207 nM 2015 PLoS ONE AptaNexus
A-2 DNA50 HepG2 214 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
A-2 DNA95 Hepatoma HepG2 cells, Human 214 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
JHIT6 DNA25 HepG2 249 nM 2015 PLoS ONE AptaNexus
JHIT3 DNA25 HepG2 272 nM 2015 PLoS ONE AptaNexus
JHIT7 DNA25 HepG2 289 nM 2015 PLoS ONE AptaNexus
HCA#3 DNA76 HepG2 305 nM 2016 PLoS ONE AptaNexus
JHIT5 DNA25 HepG2 334 nM 2015 PLoS ONE AptaNexus
JHIT4 DNA25 HepG2 349 nM 2015 PLoS ONE AptaNexus
F-1 DNA50 HepG2 370 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
F-1 DNA95 Hepatoma HepG2 cells, Human 370 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas
A-1 DNA50 HepG2 450 nM 2013 Bioorganic & Medicinal Chemistry Letters AptaNexus
A-1 DNA95 Hepatoma HepG2 cells, Human 450 nM source Kd doi:10.1016/j.bmcl.2013.01.040 UTexas